AZD6244 (ARRY-142886)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD6244 (ARRY-142886), covering 2025-11-13 to 2025-11-13. Get the full timeline:
Most recent: Clinical Trial Update: AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies [Phase 1]